Altria seeks FDA marketing order for oral nicotine pouch products

[June 27, 2024]  (Reuters) - Tobacco giant Altria said on Wednesday it had submitted Premarket Tobacco Product Applications (PMTAs) to the U.S. Food and Drug Administration for its on! Plus oral nicotine pouch products.

The FDA had authorized four of Altria's menthol e-cigarette products last week for sale in the U.S., making them the first ever flavored vapes the agency has permitted on the market.

On! Plus is a spit-less oral tobacco-derived nicotine pouch. Tobacco companies have been pushing towards alternatives for traditional tobacco products amid stricter regulation and greater health awareness among consumers.

(Reporting by Juveria Tabassum; Editing by Krishna Chandra Eluri)

A woman poses with a cigarette in front of Altria logo in this illustration taken July 26, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

[© 2024 Thomson Reuters. All rights reserved.]This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.